Evaluation of Simvastatin as CDK4 Inhibitor for the Treatment of Colon Cancer Associated with Diabetes Mellitus
Gajjar, Saumitra
Evaluation of Simvastatin as CDK4 Inhibitor for the Treatment of Colon Cancer Associated with Diabetes Mellitus - Ahmedabad Institute of Pharmacy, Nirma University 2017 - 96p.
Guided by Dr. Bhoomika M. Patel
615.1 / GAJ
Evaluation of Simvastatin as CDK4 Inhibitor for the Treatment of Colon Cancer Associated with Diabetes Mellitus - Ahmedabad Institute of Pharmacy, Nirma University 2017 - 96p.
Guided by Dr. Bhoomika M. Patel
615.1 / GAJ